53874-72-9

Basic information

• Product Name: 2-AMINO-3,5-DICHLOROBENZALDEHYDE
• Synonyms: 2-AMINO-3,5-DICHLOROBENZALDEHYDE
• CAS NO: 53874-72-9
• Molecular Formula: C₇H₅Cl₂NO
• Molecular Weight: 190.03
• Mol File: 53874-72-9.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 2-AMINO-3,5-DICHLOROBENZALDEHYDE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-AMINO-3,5-DICHLOROBENZALDEHYDE(53874-72-9)
• EPA Substance Registry System: 2-AMINO-3,5-DICHLOROBENZALDEHYDE(53874-72-9)

Safety Data

• Hazardous Substances Data: 53874-72-9(Hazardous Substances Data)

Usage

General Description

2-Amino-3,5-dichlorobenzaldehyde is a compound with the molecular formula C7H5Cl2NO. It is a benzaldehyde derivative with two chlorine atoms and an amino group attached to the benzene ring. It is commonly used as an intermediate in the synthesis of pharmaceuticals and organic compounds. The compound has been studied for its potential applications in pharmaceutical research, particularly in the development of new drugs and therapies. Its chemical properties and reactivity make it valuable in the production of various chemical products.

Upstream product

• 37585-29-8 (2-amino-3,5-dichloro-phenyl)-methanol 
• 59178-12-0 3,5-dichloro-2-nitrobenzaldehyde 
• 10203-08-4 3,5-dichlorobenzaldehyde 

Downstream Products

• 1254343-20-8 (S)-5,7-dichloro-2-phenyl-1,2,3,4-tetrahydroacridine 
• 15396-39-1 2-bromo-3,5-dichloro-benzoic acid 
• 873983-89-2 2-bromo-3,5-dichlorobenzaldehyde 

Relevant articles and documents

Chiral Phosphoric-Acid-Catalyzed Cascade Prins Cyclization

Asymmetric Prins cyclization of in situ generated quinone methides and o-aminobenzaldehyde has been developed with chiral phosphoric acid as an efficient catalyst. This unconventional method provides a facile access to diverse functionalized trans-fused pyrano-/furo-tetrahydroquinoline derivatives in excellent yield and with excellent diastereo- and enantioselectivities (up to 99% yield and 99% ee). Mechanistic studies suggested that the three adjacent tertiary stereocenters were constructed through the sequential formation of C-O, C-C, and C-N bonds.

HCV INHIBITORS AND METHODS OF USING THEM

The present invention comprises tetrazoloquinoline-compounds that are inhibitors of HCV. Compositions comprising the compounds in combination with a pharmaceutically acceptable carrier are also disclosed, as are methods of using the compounds and composit